The team found that mice with higher levels of galanin, a protein within brain nerve cells, were resistant to Multiple Sclerosis. Scientists already knew that galanin plays a protective role in both the central and peripheral nerve systems – when a nerve is injured levels of galanin increase dramatically in an attempt to limit cell death. But now researchers have effectively proved that mice that were given high levels of galanin don’t develop Multiple Sclerosis.

Related articles by Zemanta

• You: 'Dramatic' breakthrough in MS research (guardian.co.uk)
• MS and Diet: Should you eat low-fat to treat your MS? (brassandivory.blogspot.com)

Healing Ride

This post covers one of my favorite topics, therapeutic riding. Because of some surgery riding was impossible. I have received comments from others about how therapeutic riding program has been very effective. If you are involved in his type therapy please let me hear from you.


Healing Ride | clarionledger.com | The Clarion-Ledger: "DREW IS KNOWN AS 'PRETTY BOY' — A 12-year-old palomino who used to perform in western pleasure shows.

Now, the gentle horse is helping people improve their health.

He is one of three horses used at RideAbility Therapeutic Riding Center, a nonprofit organization in Florence that helps people with disabilities through supervised horseback riding.

'We work with those who are battling a lot of different things - from autism to cerebral palsy to multiple sclerosis,' says Christy Henderson, executive director and certified instructor at RideAbility. 'Part of our motto is body, mind and spirit, and we truly believe that therapeutic riding helps in all those areas."

Related articles by Zemanta

• Children live life with disability and no diagnosis (ctv.ca)

Multiple Sclerosis Relapse Rate Reduced By Nearly Half With Use of Two New Drugs - Wellsphere

Multiple Sclerosis Relapse Rate Reduced By Nearly Half With Use of Two New Drugs - Wellsphere: "Cladribine and fingolimod, two new oral drugs, have been shown to decrease the relapse rate in people who suffer from multiple sclerosis. The drugs could become the first treatments for the disease that does not require regular injections or infusions, if they gain approval by the U.S. Food and Drug Administration (FDA)."

Related articles by Zemanta

• Leukemia Risk from Multiple Sclerosis Drug May Be Up (nlm.nih.gov)

Methylprednisolone plus IFN beta and relapsing-remitting MS: the NORMIMS study | News | MS Trust - Information, education, research and support

Image via Wikipedia

Methylprednisolone plus IFN beta and relapsing-remitting MS: the NORMIMS study | News | MS Trust - Information, education, research and support: "Adding oral methylprednisolone (MP) to the standard treatment of subcutaneous interferon beta-1a (IFNb-1a) substantially reduces the relapse rate in patients with relapsing-remitting multiple sclerosis (RRMS), according to a study published early online and appearing in the June"